![]() Amgen Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics. | ![]() Adaptive Biotechnologies Adaptive Biotechnologies (formerly known as Adaptive TCR) is a company that develops diagnostics and therapeutic tools based on the immune response to disease. | ||
Founding Date | Founding Date 2009 | Founding Date 1980 | Founding Date 2009 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Santa Monica, US HQ Hoofddorp, NL London, GB El Segundo, US Emeryville, US Frederick, US Oceanside, US see more | Locations Thousand Oaks, US HQ Hydra, DZ Vicente López, AR Sydney, AU Wien, AT Diegem, BE Santo Amaro, BR see more | Locations Seattle, US HQ New York, US South San Francisco, US |
Employees | Employees 3,9671% decrease | Employees 25,200 | Employees 70910% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 170.4 b | Valuation ($) 694.6 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $36.8b (FY, 2025) | Revenue (est.) $277m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $12b (FY, 2025) | Cost of goods $71.4m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $24.7b (FY, 2025) | Gross profit $205.6m (FY, 2025) |
Net income | Net income N/A | Net income $7.7b (FY, 2025) | Net income ($59.5m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 85.3m | Total funding raised N/A | Total funding raised $ 525m |

Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.
View company
Adaptive Biotechnologies (formerly known as Adaptive TCR) is a company that develops diagnostics and therapeutic tools based on the immune response to disease.
View company